Sharpe ratio
0.48Return earned for the risk taken.
Moderate
Moderate risk-adjusted returns. The reward for risk has been average.
+22.10%1Y Absolute Return
-0.27%1D
Loading NAV history…
Past performance is not an indicator of future returns.
Returns calculator comparison
Compare an illustrative investment outcome across return assumptions.
| Asset | Projected corpus | Total invested | Gain | Annual return |
|---|---|---|---|---|
| Motilal Oswal Nifty MidSmall Healthcare Index Fund- Direct Plan-GrowthFund 1Y annualised return · 5Y history unavailable | ₹12,88,686 | ₹7,32,612 | ₹5,56,074 | +22.10% |
| EPFIllustrative annual assumption | ₹8,95,132 | ₹7,32,612 | ₹1,62,520 | +8.25% |
| Residential propertyIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| PPFIllustrative annual assumption | ₹8,69,819 | ₹7,32,612 | ₹1,37,207 | +7.10% |
| Bank fixed depositIllustrative annual assumption | ₹8,56,981 | ₹7,32,612 | ₹1,24,369 | +6.50% |
| GoldIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| Savings accountIllustrative annual assumption | ₹7,86,827 | ₹7,32,612 | ₹54,215 | +3.00% |
Illustration only. Fund results use the available NAV-derived annualised return and can be negative. Reference rows are assumptions, not current quoted rates or guaranteed returns; property excludes transaction costs, taxes, and liquidity constraints. Mutual fund investments are subject to market risk.
Wealth multiple
₹1 became₹1.14
₹1 Lakh since launch₹1.14 Lakh
Fund age2.0 yrs
Fund information
Scheme code153023
ISININF247L01EA7
BenchmarkNifty MidSmall Healthcare TRI
CategoryOther Scheme - Index Funds
Expense ratio0.79%
Exit loadExit load of 1%, if redeemed within 15 days.
Minimum SIP₹500 SIP
Return comparison
17th / 1122 in category| Period | Fund | Benchmark | Category avg |
|---|---|---|---|
| 1M | +191.38% | — | — |
| 3M | +17.25% | — | — |
| 6M | +27.02% | — | — |
| 1Y | +22.10% | — | +1.74% |
| Since Launch | +13.64% | — | — |
Risk-adjusted performance
Every measure is expanded with a plain-language reading of the latest calculated value.
Sortino ratio
0.68Return earned while limiting downside risk.
Moderate
Moderate downside risk-adjusted performance.
Standard deviation
15.48%How much the fund’s returns fluctuate over time.
High volatility
Returns can swing significantly.
Beta
—How closely the fund moves with the market.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Alpha
—Extra return generated above the benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Treynor ratio
—Return earned for each unit of market risk taken.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Calmar ratio
0.78How well the fund rewarded investors relative to its biggest decline.
Good
Good return relative to the drawdowns experienced.
Information ratio
—How consistently the fund outperformed its benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Portfolio allocation
Latest disclosed portfolio mix
Asset allocation
Allocation data has not been disclosed.
Market cap allocation
Sector allocation
Equity exposure by sector
Top holdings
10 of 31 disclosed positions
| Holding | Sector | Instrument type | Weight |
|---|---|---|---|
| Laurus Labs Ltd | Healthcare | Equity | 10.77% |
| Lupin Ltd | Healthcare | Equity | 8.94% |
| Fortis Healthcare Ltd | Healthcare | Equity | 7.5% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 6.66% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 5.13% |
| Alkem Laboratories Ltd | Healthcare | Equity | 5.13% |
| Biocon Ltd | Healthcare | Equity | 4.63% |
| Mankind Pharma Ltd. | Healthcare | Equity | 4.26% |
| Ipca Laboratories Ltd | Healthcare | Equity | 3.7% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 3.18% |
Fund management
SW
Swapnil P Mayekar
Since 2024 · Prior to joining Motilal Oswal AMC he worked with Business Standard Limited from Aug 2005 to Feb 2010.
Mr. Mayekar is an M.Com from Mumbai University and also holds an Advanced Diploma in Business Administration from Welingkar, Mumbai.
RA
Rakesh Shetty
Since 2024 · Prior to joining Motilal Oswal Mutual Fund, he has worked with Company engaged in Capital Market Business wherein he was in charge of equity and debt ETFs, customized indices and has also been part of product development.
Mr. Shetty has done B.Com
DI
Dishant Mehta
Since 2024 · Mr. Dishant Mehta has more than 11 years of experience and expertise in Financial markets across different segment -Equities, Derivatives, Commodities and Currencies
Bachelors of Science (B.SC)
Compare similar funds
No comparable category funds are available yet.
Summary
A very high-risk other scheme - index funds fund. Losses and swings stayed contained — worst fall -17.5%, volatility 15.5%. Healthcare makes up 100% — trouble in that sector hits the whole fund.
Strengths
- Losses and swings stayed contained — worst fall -17.5%, volatility 15.5%.
- Recovered from its worst fall in 4 months.
- Ranks 17 of 1122 in its category over 1 year.
Weaknesses
- None
Ideal investor
- Needs a 5+ years horizon to ride out its very high risk level.
- Good fit for SIPs — spreading purchases smooths out 15.5% volatility.
Risk drivers
- Healthcare makes up 100% — trouble in that sector hits the whole fund.